-
Mashup Score: 10Us - Amyloidosis Foundation - 6 month(s) ago
Supporting amyloidosis patients and their families while promoting research, education and awareness. www.amyloidosis.org 1-877-AMYLOID info@amyloidosis.org
Source: secure.qgiv.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2ATTR Amyloidosis: 1 in 4 Patients Experience Neurological and Cardiac Symptoms - Patient Worthy - 7 month(s) ago
Don’t miss this story about the latest ATTR amyloidosis research.
Source: patientworthy.comCategories: General Medicine News, Onc News and JournalsTweet-
RT @PatientWorthy: ATTR Amyloidosis: 1 in 4 Patients Experience Neurological and Cardiac Symptoms https://t.co/GH6FJcnVjn #Amyloidosis #ATT…
-
-
Mashup Score: 1What's new and exciting in ATTR cardiac amyloidosis in 2024 | Amyloidosis Foundation - 8 month(s) ago
Join Dr. Fredrick Ruberg and Dr. Omar Siddiqi as they discuss the general overview of ATTR treatment with new developments over the past…
Source: www.pathlms.comCategories: General Medicine News, Onc News and JournalsTweet-
🧬🧬🧬APRIL WEBINAR🧬🧬🧬 What's new and exciting in ATTR cardiac amyloidosis in 2024 TO REGISTER, CLICK THIS LINK: https://t.co/fzZHSfd435 OR USE THE QR CODE. April 29th, 3:00 pm ET Presenters: Dr. Frederick Ruberg and Dr. Omar Siddiqi https://t.co/3lpbJdXLHP
-
-
Mashup Score: 4Transthyretin Amyloid Cardiomyopathy Study | See If You May Qualify | DepleTTR-CM Study - 8 month(s) ago
A clinical research study for transthyretin amyloid cardiomyopathy (ATTR-CM). See if you may qualify for the DepleTTR-CM Study.
Categories: General Medicine News, Onc News and JournalsTweet-
Seeking a new option to help manage your ATTR-CM? Check out the DepleTTR-CM Study, which evaluates an amyloid depleter investigational medication that may help improve ATTR-CM symptoms and overall heart health. To learn more, visit https://t.co/oqflTnCTsb https://t.co/ecgS1IUOqu
-
-
Mashup Score: 3Transthyretin Amyloid Cardiomyopathy Study | See If You May Qualify | DepleTTR-CM Study - 8 month(s) ago
A clinical research study for transthyretin amyloid cardiomyopathy (ATTR-CM). See if you may qualify for the DepleTTR-CM Study.
Categories: General Medicine News, Onc News and JournalsTweet-
Seeking a new option to help manage your ATTR-CM? Check out the DepleTTR-CM Study, which evaluates an amyloid depleter investigational medication that may help improve ATTR-CM symptoms and overall heart health. To learn more, visit https://t.co/oqflTnCTsb https://t.co/ecgS1IUOqu
-
-
Mashup Score: 102024 Light The Night for Amyloidosis Month | Amyloidosis Foundation - 10 month(s) ago
“Light the Night for Amyloidosis” is an awareness campaign created to draw attention to amyloidosis symptoms, diagnosis, treatment, and hopefully a cure! Since ‘Amyloidosis Awareness Month’ occurs in March, we are asking everyone to light up their porch/entryway with red bulbs in March. We have also contacted many US landmarks and businesses to do the same in March 2023. Below is a list of the approved requests, along with the date the lighting will occur. Please join us in our “Light the Night for
Source: amyloidosis.orgCategories: General Medicine News, Onc News and JournalsTweet-
🚨🚨🚨 List of sites for 'Light the Night for Amyloidosis' 🚨🚨🚨 Sites are being added almost daily! Check back often to see if there's one near you! https://t.co/ERZiFdIJdY https://t.co/iYJNO00HGz
-
-
Mashup Score: 5Ultromics partners with Pfizer to advance EchoGo AI technology - 10 month(s) ago
Ultromics has partnership with Pfizer to expedite the development and pursue FDA clearance for its AI platform to detect cardiac amyloidosis.
Source: www.medicaldevice-network.comCategories: General Medicine News, Onc News and JournalsTweet-
Good read: Ultromics’ EchoGo Amyloidosis algorithm has been designed for early detection of cardiac amyloidosis. https://t.co/fKa4ydXDgT
-
-
Mashup Score: 4Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv) - 11 month(s) ago
Scientific Reports – Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet-
Good article stating early identification of ATTRv amyloidosis disease onset is still often delayed due to the lack of validated biomarkers of this disease. #Amyloidosis #ATTRv #hATTR #HereditaryAmyloidosis https://t.co/WPjfj0KHoR
-
-
Mashup Score: 1
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare.
Source: press.aarp.orgCategories: General Medicine News, Onc News and JournalsTweet-
Sharing from AARP: CMS taking critical step to bring down prescription drug prices, announcing today the Part D drugs selected for price negotiations. " finally bring much needed access and relief to American families" Read the full statement: https://t.co/H8nM2iH4ru https://t.co/Cntw28QBk8
-
-
Mashup Score: 4Untangling Amyloidosis - 12 month(s) ago
PROGRAM SCHEDULE / GUEST FACULTY: Welcome Remarks Jeffrey Zonder, MD Karmanos Cancer Institute MI Making the Diagnosis and Assigning Prognosis of AL…
Source: untanglingamyloidosis.comCategories: General Medicine News, Onc News and JournalsTweet-
Register TODAY for this "can't miss" event; Untangling Amyloidosis 🧬 In-person or virtual FRIDAY, DECEMBER 8, 2023 11:00AM - 2:00PM PST https://t.co/ixmN2iScce https://t.co/hGy1AHCH3B
-
❣️ REGISTRATION IS OPEN for our annual Run - Walk - Roll - Bike ❣️ Registration includes a free t-shirt with a new design!!! Participate anywhere and at any time between May 15 and September 15. REGISTER HERE⬇️ https://t.co/cVbHDulyfb https://t.co/mlV1OcQzqO